(Reuters) - Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said its benefits outweighed any risks. Reports of rare instances of blood clotting had temporarily halted inoculations.
Problem, Solution, SitRep, or ?:
Recent Comments